1,3-bis-([3-[3-[3-(4-{3-[3-nitro-5-(galactopyranosyloxy)benzoylamino]propyl}piperazin-1-yl)propylamino-3,4-dioxocyclobutenyl]aminopropoxyethoxyethoxy]propyl]aminocarbonyloxy)-2-aminopropane

Term ID

CHEBI:41279

Synonyms

1,3-BIS-([3-[3-[3-(4-{3-[3-NITRO-5-(GALACTOPYRANOSYLOXY)-BENZOYLAMINO]-PROPYL}-PIPERAZIN-1-YL)-PROPYLAMINO-3,4-DIOXO-CYCLOBUTENYL]-AMINO-PROPOXY-ETHOXY-ETHOXY]-PROPYL-]AMINO-CARBONYLOXY)-2-AMINO-PROPANE
2-amino-19-{[2-({3-[4-(3-{[(3-nitro-5-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}phenyl)carbonyl]amino}propyl)piperazin-1-yl]propyl}amino)-3,4-dioxocyclobut-1-en-1-yl]amino}-5-oxo-4,10,13,16-tetraoxa-6-azanonadec-1-y

Definition

References

pdb-ccd:BV4

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from 1,3-bis-([3-[3-[3-(4-{3-[3-nitro-5-(galactopyranosyloxy)benzoylamino]propyl}piperazin-1-yl)propylamino-3,4-dioxocyclobutenyl]aminopropoxyethoxyethoxy]propyl]aminocarbonyloxy)-2-aminopropane

Phenotype where environments contain 1,3-bis-([3-[3-[3-(4-{3-[3-nitro-5-(galactopyranosyloxy)benzoylamino]propyl}piperazin-1-yl)propylamino-3,4-dioxocyclobutenyl]aminopropoxyethoxyethoxy]propyl]aminocarbonyloxy)-2-aminopropane

Phenotype modified by environments containing 1,3-bis-([3-[3-[3-(4-{3-[3-nitro-5-(galactopyranosyloxy)benzoylamino]propyl}piperazin-1-yl)propylamino-3,4-dioxocyclobutenyl]aminopropoxyethoxyethoxy]propyl]aminocarbonyloxy)-2-aminopropane

Phenotype affecting 1,3-bis-([3-[3-[3-(4-{3-[3-nitro-5-(galactopyranosyloxy)benzoylamino]propyl}piperazin-1-yl)propylamino-3,4-dioxocyclobutenyl]aminopropoxyethoxyethoxy]propyl]aminocarbonyloxy)-2-aminopropane

Human Disease Model